C
Clavister Holding AB
STO:CLAV
Clavister Holding AB
STO:CLAV
Price:
5.14
SEK
8.48%
Market Closed
Market Cap:
kr1.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Clavister Holding AB
STO:CLAV
|
SE |
|
Sensyne Health PLC
LSE:SENS
|
UK |
|
V
|
Viet Thang Corp
VN:TVT
|
VN |
|
Vitrolife AB
STO:VITR
|
SE |
|
Antigenics Inc
OTC:ANTI
|
US |
|
Gaxos.AI Inc
NASDAQ:GXAI
|
US |
|
X
|
Xebra Brands Ltd
CNSX:XBRA
|
CA |
|
V
|
Vikas Lifecare Ltd
BSE:542655
|
IN |
|
Bridgestone Corp
TSE:5108
|
JP |
|
T
|
Tien Len Steel Corporation JSC
VN:TLH
|
VN |
|
P
|
Pangenomic Health Inc
CNSX:NARA
|
CA |
Balance Sheet
Balance Sheet Decomposition
Clavister Holding AB
Clavister Holding AB
Balance Sheet Decomposition is not available for
Clavister Holding AB
Clavister Holding AB
Balance Sheet
Clavister Holding AB
Clavister Holding AB
Currency: SEK
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash & Cash Equivalents |
1
|
3
|
8
|
45
|
11
|
44
|
75
|
26
|
82
|
71
|
143
|
50
|
42
|
39
|
83
|
96
|
|
| Cash |
1
|
3
|
8
|
45
|
11
|
44
|
75
|
26
|
82
|
71
|
143
|
50
|
42
|
39
|
83
|
96
|
|
| Total Receivables |
17
|
23
|
17
|
9
|
9
|
3
|
21
|
34
|
25
|
38
|
39
|
35
|
43
|
37
|
42
|
71
|
|
| Accounts Receivables |
17
|
23
|
17
|
9
|
9
|
3
|
21
|
34
|
25
|
38
|
39
|
34
|
43
|
37
|
42
|
71
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Inventory |
2
|
5
|
6
|
3
|
6
|
6
|
7
|
8
|
5
|
8
|
7
|
6
|
14
|
16
|
17
|
11
|
|
| Other Current Assets |
1
|
7
|
6
|
2
|
0
|
3
|
0
|
0
|
19
|
18
|
6
|
15
|
9
|
12
|
22
|
0
|
|
| Total Current Assets |
21
|
38
|
37
|
58
|
29
|
55
|
102
|
69
|
132
|
135
|
196
|
106
|
108
|
104
|
164
|
178
|
|
| PP&E Net |
1
|
1
|
1
|
3
|
2
|
2
|
1
|
2
|
27
|
20
|
16
|
8
|
4
|
19
|
17
|
14
|
|
| PP&E Gross |
0
|
1
|
1
|
3
|
2
|
2
|
0
|
0
|
27
|
20
|
16
|
8
|
4
|
0
|
17
|
0
|
|
| Accumulated Depreciation |
0
|
3
|
3
|
4
|
0
|
4
|
0
|
0
|
2
|
11
|
16
|
18
|
20
|
0
|
1
|
0
|
|
| Intangible Assets |
21
|
22
|
27
|
28
|
27
|
34
|
107
|
56
|
66
|
78
|
102
|
111
|
111
|
109
|
110
|
111
|
|
| Goodwill |
0
|
6
|
6
|
5
|
5
|
4
|
0
|
53
|
53
|
52
|
52
|
67
|
67
|
67
|
67
|
67
|
|
| Note Receivable |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
41
|
31
|
17
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
66
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
26
|
26
|
49
|
0
|
82
|
77
|
0
|
18
|
0
|
0
|
0
|
0
|
30
|
|
| Other Assets |
0
|
6
|
6
|
5
|
5
|
4
|
0
|
53
|
53
|
52
|
52
|
67
|
67
|
67
|
67
|
67
|
|
| Total Assets |
43
N/A
|
67
+55%
|
70
+5%
|
120
+71%
|
101
-16%
|
145
+43%
|
277
+92%
|
302
+9%
|
386
+28%
|
303
-21%
|
383
+26%
|
292
-24%
|
291
0%
|
299
+3%
|
359
+20%
|
401
+12%
|
|
| Liabilities | |||||||||||||||||
| Accounts Payable |
11
|
13
|
6
|
5
|
0
|
5
|
0
|
0
|
10
|
5
|
18
|
10
|
10
|
17
|
16
|
15
|
|
| Accrued Liabilities |
8
|
13
|
16
|
13
|
0
|
11
|
0
|
0
|
64
|
75
|
91
|
81
|
22
|
29
|
40
|
34
|
|
| Short-Term Debt |
7
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
6
|
2
|
2
|
0
|
1
|
0
|
0
|
6
|
60
|
6
|
15
|
9
|
70
|
5
|
25
|
|
| Other Current Liabilities |
3
|
8
|
6
|
14
|
6
|
18
|
49
|
35
|
6
|
7
|
31
|
13
|
74
|
165
|
103
|
120
|
|
| Total Current Liabilities |
32
|
47
|
29
|
34
|
24
|
36
|
49
|
35
|
86
|
147
|
145
|
119
|
116
|
280
|
164
|
193
|
|
| Long-Term Debt |
6
|
7
|
13
|
11
|
9
|
9
|
0
|
0
|
232
|
245
|
225
|
226
|
279
|
243
|
240
|
98
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
8
|
11
|
5
|
0
|
9
|
20
|
58
|
0
|
0
|
0
|
0
|
59
|
4
|
40
|
15
|
|
| Total Liabilities |
38
N/A
|
62
+62%
|
54
-13%
|
49
-8%
|
33
-33%
|
54
+62%
|
69
+28%
|
92
+34%
|
319
+245%
|
393
+23%
|
371
-6%
|
345
-7%
|
455
+32%
|
528
+16%
|
443
-16%
|
307
-31%
|
|
| Equity | |||||||||||||||||
| Common Stock |
1
|
1
|
3
|
1
|
0
|
2
|
0
|
0
|
2
|
3
|
5
|
6
|
6
|
6
|
27
|
0
|
|
| Retained Earnings |
3
|
2
|
12
|
0
|
0
|
226
|
0
|
0
|
470
|
684
|
765
|
856
|
969
|
1 034
|
1 090
|
0
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
213
|
0
|
315
|
0
|
0
|
534
|
592
|
771
|
797
|
800
|
800
|
979
|
0
|
|
| Other Equity |
2
|
2
|
1
|
142
|
0
|
0
|
208
|
210
|
0
|
0
|
0
|
0
|
0
|
229
|
84
|
94
|
|
| Total Equity |
5
N/A
|
5
+4%
|
17
+206%
|
71
+330%
|
68
-4%
|
91
+34%
|
208
+129%
|
210
+1%
|
67
-68%
|
89
N/A
|
12
N/A
|
54
N/A
|
164
-204%
|
229
-40%
|
84
+63%
|
94
N/A
|
|
| Total Liabilities & Equity |
43
N/A
|
67
+55%
|
70
+5%
|
120
+71%
|
101
-16%
|
145
+43%
|
277
+92%
|
302
+9%
|
386
+28%
|
303
-21%
|
383
+26%
|
292
-24%
|
291
0%
|
299
+3%
|
359
+20%
|
401
+12%
|
|
| Shares Outstanding | |||||||||||||||||
| Common Shares Outstanding |
14
|
14
|
14
|
14
|
16
|
19
|
24
|
25
|
25
|
27
|
102
|
111
|
111
|
111
|
268
|
371
|
|
Switch to:
Switch to:
See Also
Discover More
